Gerresheimer enlarged a cleanroom, installed a high-performance furnace, and automated testing and packaging systems for pharmaceutical glass packaging in Essen, Germany.
Gerresheimer completed a modernization of its plant in Essen, Germany, including renovation of its clear-glass furnace used to produce glass containers for the pharmaceutical industry, the company announced in an Oct. 28, 2019 press release. The improved furnace technology is more powerful but uses less energy, making it more sustainable than its predecessor. The high-performance furnace also adds new capacity for the production of injection and infusion bottles from type II glass for parenteral solutions.
“We want to make production more environmentally friendly while remaining an efficient partner for our customers,” said Dr. Jürgen Unruh, CEO of Gerresheimer Essen, in the release.
According to the release, Gerresheimer is using the renovation as an opportunity to fundamentally modernize the plant. The production hall and cleanroom will be enlarged, and the testing and packaging technology will be further automated. The energy efficiency of the new white glass tank will be improved while at the same time reducing specific carbon dioxide emissions. In addition, a new candle filter sustainably reduces nitrogen oxide content.
The company’s plant in Essen serves as a center of excellence for the production of type II glass. The Gerresheimer Group has production sites for molded glass in Europe, the Americas, and Asia. Three of these are German sites based in Essen, Lohr, and Tettau.
Source: Gerresheimer
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.